Literature DB >> 18709694

Relationship between caseload volume and outcome for systemic lupus erythematosus treatment: the experience of Taiwan.

Tzu-Feng Wang1, Herng-Ching Lin.   

Abstract

OBJECTIVE: To determine if a physician's experience or hospital caseload volume is associated with in-hospital mortality of patients with systemic lupus erythematosus (SLE).
METHODS: We used data from Taiwan's National Health Insurance Research Database covering 2002 to 2004. A total of 8536 hospital admissions citing a principal diagnosis of SLE were selected. Hospitals with an average of > 50, 26-50, and < 26 SLE cases per year were categorized as high, medium, and low-caseload-volume hospitals, respectively. Physician caseload volume was defined as low (< 1 SLE case per year), medium (1-3 cases per year), and high-volume (> 3 cases per year). Multivariate logistic regression analyses employing generalized estimated equations were performed to assess the independent association between physician or hospital SLE caseload volume and in-hospital mortality, after adjusting for other factors.
RESULTS: We found that in-hospital mortality declined with increasing physician caseload volume (3.0%, 1.0%, and 0.8% for low, medium, and high-volume physicians, respectively), with the adjusted odds of in-hospital mortality for patients treated by low-volume physicians being 2.681 (p < 0.05) times greater than for patients treated by medium-volume physicians, and 3.195 (p < 0.001) times greater than for those treated by high-volume physicians. No significant relationship was found between in-hospital mortality and hospital SLE caseload volume (p = 0.896).
CONCLUSION: We concluded that the factor of physicians' experience treating SLE is more crucial in determining in-hospital mortality than a hospital's annual SLE caseload.

Entities:  

Mesh:

Year:  2008        PMID: 18709694

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  3 in total

1.  Diffusion of new medication across different income groups under a universal health insurance program: an example involving newly enlisted nonsteroidal anti-inflammatory drugs for elderly osteoarthritis patients.

Authors:  Pen-Jen Wang; Yiing-Jenq Chou; Cheng-Hua Lee; Christy Pu
Journal:  Int J Public Health       Date:  2010-03-17       Impact factor: 3.380

2.  Tuberculosis as a risk factor for systemic lupus erythematosus: results of a nationwide study in Taiwan.

Authors:  Yu-Chao Lin; Shinn-Jye Liang; Yi-Heng Liu; Wu-Huei Hsu; Chuen-Ming Shih; Fung-Chang Sung; Wei Chen
Journal:  Rheumatol Int       Date:  2011-03-18       Impact factor: 2.631

3.  Characteristics of comorbidities and costs among patients who died from systemic lupus erythematosus in Taiwan.

Authors:  Shih-Chao Kang; Shinn-Jang Hwang; Yu-Sheng Chang; Chung-Tei Chou; Chang-Youh Tsai
Journal:  Arch Med Sci       Date:  2012-09-08       Impact factor: 3.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.